{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:37:36Z","timestamp":1784371056301,"version":"3.55.0"},"reference-count":34,"publisher":"Bentham Science Publishers Ltd.","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/legalcode"}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMIR"],"published-print":{"date-parts":[[2025,9,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Adrenal incidentalomas have increased over the past years. Although there are a lot of studies related to the frequency of adrenal masses and\ncomorbidities, whether patients with functional or nonfunctional adrenal masses have higher risk is still a controversial issue.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A total of 464 patients (female\/male: 309\/155) with adrenal incidentalomas were evaluated and followed up for 8 years. The patients were divided\ninto 5 subgroups, including Autonomous Cortisol Secretion (ACS), Cushing Syndrome (CS), Pheochromocytoma (Pheo), Non-functional Adrenal\nIncidentalomas (NFAI), and Primary Aldosteronism (PA).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>While 336 (72.4%) of the patients had NFAI, the others suffered from ACS (10.8%), CS (4.3%), Pheo (4.1%), and PA (8.4%), respectively. When\ncomparing biochemical and demographical data, BMI (p=0.77), Hba1c (p=0.495), FPG (p=0.28), LDL (p=0.66), and HDL (p=0.521) were similar\namong the patients with functional and nonfunctional adrenal masses. The most common comorbidities were hypertension (n=259, 55.8%),\ndiabetes mellitus (n=158, 34.1%), and dyslipidemia (33.4%), respectively. While 84 (32.4%) patients with hypertension had functional adrenal\nmasses, the others (n=175, 67.6%) had non-functional adrenal incidentalomas. In subgroup analyses, hypertension was more common in patients\nwith PA (87.2% vs. 72%, p=0.001) and ACS. In multivariable regression analyses, hypertension (p&lt;0.001), cortisol (p=0.003), and aldosterone\n(p=0.04) levels were significantly correlated with functionality.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Hypertension was the most common comorbidity in patients with adrenal adenomas, especially in functional adrenal adenomas related to serum\ncortisol and aldosterone levels.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115734056347340241009102228","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T04:09:46Z","timestamp":1754539786000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Outcomes of Patients with Adrenal Incidentaloma - Hypertension being a Continuous Risk Factor for the Presence of Comorbidity: A Single Center\u2019s Eight-year Experience"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0976-159X","authenticated-orcid":true,"given":"Gamze","family":"Akkus","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-7342","authenticated-orcid":true,"given":"Ulcaz Perihan","family":"Aksoydan","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-6106","authenticated-orcid":true,"given":"Fulya","family":"Odabas","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0162-4574","authenticated-orcid":true,"given":"H\u00fclya","family":"Binokay","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5376-9874","authenticated-orcid":true,"given":"Murat","family":"Sert","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-7557","authenticated-orcid":true,"given":"Tamer","family":"Tetiker","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1530\/EJE-10-1147","volume":"164","author":"Terzolo M.","year":"2011","unstructured":"Terzolo M.; Stigliano A.; Chiodini I.; Loli P.; Furlani L.; Arnaldi G.; Reimondo G.; Pia A.; Toscano V.; Zini M.; Borretta G.; Papini E.; Garofalo P.; Allolio B.; Dupas B.; Mantero F.; Tabarin A.; AME Position Statement on adrenal incidentaloma. Eur J Endocrinol  2011,164(6),851-870","journal-title":"Eur J Endocrinol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1056\/NEJMcp065470","volume":"356","author":"Young W.F.","year":"2007","unstructured":"Young W.F.; Clinical practice. The incidentally discovered adrenal mass. N Engl J Med  2007,356(6),601-610","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jss.2021.07.041","volume":"269","author":"Feeney T.","year":"2022","unstructured":"Feeney T.; Madiedo A.; Knapp P.E.; Gupta A.; McAneny D.; Drake F.T.; Incidental adrenal masses: Adherence to guidelines and methods to improve initial follow-up: A systematic review. J Surg Res  2022,269,18-27","journal-title":"J Surg Res"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","volume":"69","author":"Tabarin A.","year":"2008","unstructured":"Tabarin A.; Bardet S.; Bertherat J.; Dupas B.; Chabre O.; Hamoir E.; Laurent F.; Tenenbaum F.; Cazalda M.; Lefebvre H.; Valli N.; Rohmer V.; Exploration and management of adrenal incidentalomas. Ann Endocrinol (Paris)  2008,69(6),487-500","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jama.1982.03330060041031","volume":"248","author":"Prinz R.A.","year":"1982","unstructured":"Prinz R.A.; Brooks M.H.; Churchill R.; Graner J.L.; Lawrence A.M.; Paloyan E.; Sparagana M.; Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required? JAMA  1982,248(6),701-704","journal-title":"JAMA"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S2213-8587(20)30314-4","volume":"8","author":"Ebbehoj A.","year":"2020","unstructured":"Ebbehoj A.; Li D.; Kaur R.J.; Zhang C.; Singh S.; Li T.; Atkinson E.; Achenbach S.; Khosla S.; Arlt W.; Young W.F.; Rocca W.A.; Bancos I.; Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: A population-based cohort study. Lancet Diabetes Endocrinol  2020,8(11),894-902","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1210\/endrev\/bnaa008","volume":"41","author":"Sherlock M.","year":"2020","unstructured":"Sherlock M.; Scarsbrook A.; Abbas A.; Fraser S.; Limumpornpetch P.; Dineen R.; Stewart P.M.; Adrenal incidentaloma. Endocr Rev  2020,41(6),775-820","journal-title":"Endocr Rev"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2214\/AJR.07.2799","volume":"190","author":"Song J.H.","year":"2008","unstructured":"Song J.H.; Chaudhry F.S.; Mayo-Smith W.W.; The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol  2008,190(5),1163-1168","journal-title":"AJR Am J Roentgenol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3109\/02841851.2010.516016","volume":"51","author":"Hammarstedt L.","year":"2010","unstructured":"Hammarstedt L.; Muth A.; W\u00e4ngberg B.; Bj\u00f6rneld L.; Sigurj\u00f3nsd\u00f3ttir H.A.; G\u00f6therstr\u00f6m G.; Almqvist E.; Widell H.; Carlsson S.; Ander S.; Hellstr\u00f6m M.; Adrenal lesion frequency: A prospective, cross-sectional CT study in a defined region, including systematic re-evaluation. Acta Radiol  2010,51(10),1149-1156","journal-title":"Acta Radiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1210\/jc.85.2.637","volume":"85","author":"Mantero F.","year":"2000","unstructured":"Mantero F.; Terzolo M.; Arnaldi G.; Osella G.; Masini A.M.; Al\u00ec A.; Giovagnetti M.; Opocher G.; Angeli A.; A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab  2000,85(2),637-644","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s42000-022-00406","author":"Castro M.A.","year":"2022","unstructured":"Castro M.A.; Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas. Hormones (Athens)  2022(1),51-59","journal-title":"Hormones (Athens)"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/sj.bjc.6602459","volume":"92","author":"Bernini G.P.","year":"2005","unstructured":"Bernini G.P.; Moretti A.; Oriandini C.; Bardini M.; Taurino C.; Salvetti A.; Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. Br J Cancer  2005,92(6),1104-1109","journal-title":"Br J Cancer"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1530\/EJE-08-0707","volume":"160","author":"Sereg M.","year":"2009","unstructured":"Sereg M.; Szappanos \u00c1.; T\u0151ke J.; Karlinger K.; Feldman K.; Kaszper \u00c9.; Varga I.; Gl\u00e1z E.; R\u00e1cz K.; T\u00f3th M.; Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur J Endocrinol  2009,160(4),647-655","journal-title":"Eur J Endocrinol"},{"key":"ref=14","first-page":"1","volume":"19","author":"Consensus N.I.H.","year":"2002","unstructured":"Consensus N.I.H.; Statements S.; NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d). NIH Consens State Sci Statements  2002,19(2),1-25","journal-title":"NIH Consens State Sci Statements"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1210\/jc.2010-2137","volume":"96","author":"Kumari M.","year":"2011","unstructured":"Kumari M.; Shipley M.; Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II Study. J Clin Endocrinol Metab  2011,96,1478-1485","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1055\/s-2008-1073167","volume":"40","author":"Kasperlik-Za\u0142uska A.","year":"2008","unstructured":"Kasperlik-Za\u0142uska A.; Otto M.; Cichocki A.; Ros\u0142onowska E.; S\u0142owi\u0144ska-Srzednicka J.; Jeske W.; Papierska L.; Zgliczy\u0144ski W.; Incidentally discovered adrenal tumors: A lesson from observation of 1,444 patients. Horm Metab Res  2008,40(5),338-341","journal-title":"Horm Metab Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1055\/s-2001-16234","volume":"33","author":"Tanabe A.","year":"2001","unstructured":"Tanabe A.; Naruse M.; Nishikawa T.; Yoshimoto T.; Shimizu T.; Seki T.; Takagi S.; Imaki T.; Takano K.; Autonomy of cortisol secretion in clinically silent adrenal incidentaloma. Horm Metab Res  2001,33(7),444-450","journal-title":"Horm Metab Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-16-0467","volume":"175","author":"Fassnacht M.","year":"2016","unstructured":"Fassnacht M.; Arlt W.; Bancos I.; Dralle H.; Newell-Price J.; Sahdev A.; Tabarin A.; Terzolo M.; Tsagarakis S.; Dekkers O.M.; Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the european network for the study of adrenal tumors. Eur J Endocrinol  2016,175(2),G1-G34","journal-title":"Eur J Endocrinol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1210\/jcem.87.3.8277","volume":"87","author":"Terzolo M.","year":"2002","unstructured":"Terzolo M.; Pia A.; Al\u00ec A.; Osella G.; Reimondo G.; Bovio S.; Daffara F.; Procopio M.; Paccotti P.; Borretta G.; Angeli A.; Adrenal incidentaloma: A new cause of the metabolic syndrome? J Clin Endocrinol Metab  2002,87(3),998-1003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1046\/j.1365-2265.2001.01274.x","volume":"54","author":"Midorikawa S.","year":"2001","unstructured":"Midorikawa S.; Sanada H.; Hashimoto S.; Suzuki T.; Watanabe T.; The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf)  2001,54(6),797-804","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP.15.S1.1","volume":"15","author":"Zeiger M.A.","year":"2009","unstructured":"Zeiger M.A.; Thompson G.B.; Duh Q.Y.; Hamrahian A.H.; Angelos P.; Elaraj D.; Fishman E.; Kharlip J.; Zeiger M.A.; Thompson G.B.; Duh Q-Y.; Hamrahian A.H.; Zeiger M.A.; Thompson G.B.; Duh Q-Y.; Angelos P.; Elaraj D.; Fishman E.; Hamrahian A.H.; Kharlip J.; Garber J.R.; Mechanick J.I.; Demeure M.J.; Inabnet W.B.; The american association of clinical endocrinologists and american association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract  2009,15(1)(Suppl. 1),1-20","journal-title":"Endocr Pract"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.4158\/EP15618.OR","volume":"21","author":"Patrova J.","year":"2015","unstructured":"Patrova J.; Jarocka I.; Wahrenberg H.; Falhammar H.; Clinical outcomes in adrenal incidentaloma: experience from one center. Endocr Pract  2015,21(8),870-877","journal-title":"Endocr Pract"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/eje.0.1470489","volume":"147","author":"Lib\u00e8 R.","year":"2002","unstructured":"Lib\u00e8 R.; Dall\u2019Asta C.; Barbetta L.; Baccarelli A.; Beck-Peccoz P.; Ambrosi B.; Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol  2002,147(4),489-494","journal-title":"Eur J Endocrinol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1210\/jc.2002-021069","volume":"87","author":"Koch C.A.","year":"2002","unstructured":"Koch C.A.; Pacak K.; Chrousos G.P.; The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. J Clin Endocrinol Metab  2002,87(12),5367-5384","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1365-2265.1998.00357.x","volume":"48","author":"Terzolo M.","year":"1998","unstructured":"Terzolo M.; Osella G.; Al\u00ec A.; Borretta G.; Cesario F.; Paccotti P.; Angeli A.; Subclinical Cushing\u2019s syndrome in adrenal incidentaloma. Clin Endocrinol (Oxf)  1998,48(1),89-97","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.maturitas.2018.12.002","volume":"121","author":"Sydney G.I.","year":"2019","unstructured":"Sydney G.I.; Ioakim K.J.; Paschou S.A.; Insulin resistance and adrenal incidentalomas: A bidirectional relationship. Maturitas  2019,121,1-6","journal-title":"Maturitas"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.7326\/M18-3630","volume":"171","author":"Elhassan Y.S.","year":"2019","unstructured":"Elhassan Y.S.; Alahdab F.; Prete A.; Delivanis D.A.; Khanna A.; Prokop L.; Murad M.H.; O\u2019Reilly M.W.; Arlt W.; Bancos I.; Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess. A systematic review and meta-analysis. Ann Intern Med  2019,171(2),107-116","journal-title":"Ann Intern Med"},{"key":"ref=28","first-page":"5301","volume":"86","author":"Garrapa G.G.","year":"2001","unstructured":"Garrapa G.G.; Pantanetti P.; Arnaldi G.; Mantero F.; Faloia E.; Body composition and metabolic features in women with adrenal incidentaloma or Cushing\u2019s syndrome. J Clin Endocrinol Metab  2001,86(11),5301-5306","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M16-0547","volume":"165","author":"Lopez D.","year":"2016","unstructured":"Lopez D.; Luque-Fernandez M.A.; Steele A.; Adler G.K.; Turchin A.; Vaidya A.; \u201cNonfunctional\u201d adrenal tumors and the risk for incident diabetes and cardiovascular outcomes. Ann Intern Med  2016,165(8),533-542","journal-title":"Ann Intern Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/cen.13822","volume":"89","author":"Ribeiro Cavalari E.M.","year":"2018","unstructured":"Ribeiro Cavalari E.M.; de Paula M.P.; Arruda M.; Carraro N.; Martins A.; de Souza K.; Coelho M.C.; de Oliveira e Silva de Morais N.A.; Moraes A.B.; Vieira Neto L.; Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome. Clin Endocrinol (Oxf)  2018,89(5),586-595","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1210\/jc.2014-3007","volume":"99","author":"Debono M.","year":"2014","unstructured":"Debono M.; Bradburn M.; Bull M.; Harrison B.; Ross R.J.; Newell-Price J.; Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J Clin Endocrinol Metab  2014,99(12),4462-4470","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","volume":"58","author":"Patrova J.","year":"2017","unstructured":"Patrova J.; Kjellman M.; Wahrenberg H.; Falhammar H.; Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Endocrine  2017,58(2),267-275","journal-title":"Endocrine"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"Nieman L.K.","year":"2008","unstructured":"Nieman L.K.; Biller B.M.K.; Findling J.W.; Newell-Price J.; Savage M.O.; Stewart P.M.; Montori V.M.; The diagnosis of cushing\u2019s syndrome: An endocrine society clinical practice guideline. J Clin Endocrinol Metab  2008,93(5),1526-1540","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"Di Dalmazi G.","year":"2014","unstructured":"Di Dalmazi G.; Vicennati V.; Garelli S.; Casadio E.; Rinaldi E.; Giampalma E.; Mosconi C.; Golfieri R.; Paccapelo A.; Pagotto U.; Pasquali R.; Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol  2014,2(5),396-405","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Current Medical Imaging Formerly Current Medical Imaging Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/244236","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/244236\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/244236","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:04:23Z","timestamp":1757923463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/244236\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":34,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734056347340241009102228","relation":{},"ISSN":["1573-4056"],"issn-type":[{"value":"1573-4056","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15734056347340"}}